Supplemental and Archived Hepatitis A
as Published in Morbidity and Mortality Weekly Report (MMWR)
Advisory Committee on Immunization Practices (ACIP)
These MMWR publications were published in addition to the official CDC recommendations and serve as updates until the recommendations are revised and republished. These MMWRs contain important changes or supplemental recommendations that may include policy notes, changes or updates to recommendations, and notices to readers.
NOTE: As a general rule, if the official recommendations are dated later than the supplemental recommendations listed below, the official recommendations override the older items listed below.
For your convenience, the "Archived MMWR Publications" section can be used for historical and research purposes.
Supplemental Hepatitis A Recommendations
- September 18, 2009, Vol 58, #36
Updated Recommendations from the ACIP for Use of Hepatitis A Vaccine in Close Contacts of Newly Arriving International Adoptees
October 12, 2007, Vol 56, #40
Notice to Readers: FDA Approval of an Alternate Dosing Schedule for a Combined Hepatitis A and B Vaccine (Twinrix®)
- December 9, 2005, Vol 54, #49
Notice to Readers: FDA Approval of Havrix® (Hepatitis A Vaccine, Inactivated) for Persons Aged 1-18 Years
- October 14, 2005, Vol 54, #40
Notice To Readers: FDA Approval of VAQTA® (Hepatitis A Vaccine, Inactivated) for Children Aged >1 Year
- September 21, 2001, Vol 50, #37
Notice to Readers: FDA Approval for a Combined Hepatitis A and B Vaccine
Content last reviewed on April 8, 2011
Content Source: National Center for Immunization and Respiratory Diseases